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Abstract 
Background: Evidence concerning the impact of vaping on respiratory infections 
remains contradictory. Cell and animal studies suggested that vaping may increase 
vulnerability to respiratory infections, but human data do not confirm the concern.  
Case Presentation: We present a case of a never-smoker who became a vaper and 
after a few months of e-cigarette use experienced a complete resolution of chronic 
tonsillitis and a marked improvement in tonsilloliths.  
Conclusions: As this is a never-smoker, the improvements cannot be attributed to 
smoking cessation. One possible explanation is that the improvement was due to 
antimicrobial properties of propylene glycol. The hypothesis could be tested by a trial 
of zero-nicotine e-cigarettes in patients with recurrent bacterial throat infection.   
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Background: 
Unlike conventional cigarettes, e-cigarettes (EC) deliver no combustion chemicals 
and are therefore considered to be much safer (1). Vaping may however still pose a 
degree of risk due to other chemicals present in e-liquid and due to their thermal 
degradation.  
One of the effects of vaping where there is contradictory evidence concerns the 
impact on respiratory infections. Cell and animal studies (2,3) suggested that vaping 
may increase vulnerability to respiratory infections, but human data do not confirm 
the concern and the pre-clinical findings allow alternative interpretations (4). In the 
animal study, the susceptibility to infections could be due to chronic and massive 
nicotine overdosing and stress, while in the cell study, the damage to epithelial cells 
harvested from 8 to 10 year old donors resulted from incubation in e-liquid (not e-
cigarette aerosol). Regarding human data on vaping and respiratory health, some 
transient symptoms such as throat irritation and coughing have been reported but no 
significant adverse respiratory effects were associated with EC use for up to 1.5 
years (5). In a large youth cohort, there was no link between vaping and respiratory 
symptoms when adjusting for smoking status but past EC use was linked to an 
increase in some symptoms and a decrease in wheezing (6). Asthmatic smokers 
who switched to vaping recorded significant improvements in asthma outcomes (7). 
Progressive reduction in yearly respiratory exacerbations has been documented 
throughout a 2-year reporting period in COPD patients who quit or substantially 
reduced their tobacco consumption by switching to EC use (8).An online survey of 
941 vapers that asked them about any changes in their respiratory infections found 
that 5% reported worsening, 29% reported no change, and 66% reported an 
improvement (9). A selection bias may have played a role in this surprising result, 
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but there exists a putative explanation for a genuine beneficial effect. One of the key 
ingredients of e-liquid is propylene glycol that is known to have anti-microbial effects 
(10).  
We report here on an association between vaping and chronic throat infection in a 
non-smoker who became a vaper. 
Case presentation: 
During an on-line survey of vapers (9), an unusual report was noticed from a non-
smoker who became a daily vaper. The person (LM) agreed to be contacted and we 
followed her up over several weeks and elicited the following details. 
LM is a 26-year old computer scientist. She is overall in good health, but suffered 
from ear infections in childhood and had two episodes of severe otitis media and an 
eardrum rapture in adulthood.   
Her main health problem are frequent episodes of tonsillitis that started when she 
was about seven years old. She also suffers from recurrent tonsilloliths, from about 
the age of 17.  
She would typically have sore throat upon waking, followed by some improvement 
after eating, with fluctuations throughout the day. Her tonsils would be red and 
swollen, often with white spots, and her voice would be hoarse. This would be 
accompanied by pain or discomfort when swallowing. She would cough up dark 
yellow/brown phlegm and have some discharge from her nose throughout the day. 
The problem would be present for about seven days per month. In childhood, she 
was repeatedly prescribed antibiotics. She saw two ENT specialists but was advised 
against tonsillectomy. Her current GP recommended that she waits for the infections 
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to clear by themselves and they usually do, but then return a few weeks later. Over 
the past few years, she came to accept the there is no medical treatment for her 
condition and stopped seeking further help. 
LM never smoked. Her partner stopped smoking and switched to vaping about eight 
months ago and now uses e-liquid with 0mg to 3mg/ml of nicotine. LM first tried her 
partner’s e-cigarette out of curiosity in April 2016. As her partner moved on to a 
newer EC device, she „inherited“ his old device and started to use it more regularly. 
She enjoyed the activity of vaping and progressed to using some 8-20 ml of e-liquid 
per day. She uses e-liquid with 0 – 3mg/ml nicotine with varied flavours. She can go 
without vaping for extended period of time with no discomfort. She thinks that vaping 
met her need to do something with her hands (she tends to fidget and used to bite 
her nails prior to taking up vaping) and has reduced her snacking on sweets and 
chocolate throughout the day. She likes sweet and fruity vaping flavours and enjoys 
vaping together with her partner.   
After about three months of vaping, LM noticed that her throat was not sore in the 
mornings any more. She also did not have to clear her throat and stopped coughing 
up phlegm. Her tonsilloliths were intermittent and so she waited to see if they 
improve as well. She had now been vaping for eight months and her tonsillitis has 
not recurred, and her tonsiloliths have markedly improved. In addition to this, since 
starting vaping LM has not suffered a single respiratory infection or common cold. 
LM is not sure what caused these improvements but she is enjoying them greatly.  
Discussion and conclusions: 
The present case study is of particular interest because LM is a non-smoker. 
Smoking increases susceptibility to respiratory infections (11) and so a similar 
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recovery in a smoker who switched to vaping could be ascribed to smoking 
cessation.  
No bacteriological examination was performed and case studies of course can not 
exclude coincidences and spontaneous improvements, but the reported case does 
generate a tentative hypothesis and research question.  
There is a possibility is that propylene glycol in EC aerosol affected a microbial strain 
that was causing LM problems. Nicotine at low concentration is also known to have 
anti-inflamatory effects and this may have played a role as well (13), although LM 
uses primarily nicotine free EC. A classical experiment testing antimicrobial 
properties of propylene glycol (1mg of propylene glycol vapour in two to four million 
cc.) reported achieving a complete sterilisation of air sprayed with streptococci, 
pneumococci, staphylococci, H. influenzae, other microorganisms, including 
influenza virus (12). Whether EC aerosol has the same effect remains unknown. 
LM’s case is consistent with recurrent exacerbation of chronic tonsillitis. As viruses 
more frequently cause such exacerbations than bacteria, virucidal effects of 
propylene glycol may have been involved. A trial of vaping zero-nicotine e-cigarettes 
in patients with recurrent throat infections could clarify whether this anecdotal 
observation was a coincidence, a rare idiosyncratic reaction, or an effect that could 
benefit others. 
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